Inter Chairman Visits NeMO, Supporting Neuromuscular Research
Inter Milan Chairman Giuseppe Marotta recently visited the Centro clinico nemo in milan, a leading national center dedicated to neuromuscular and neurodegenerative diseases. The visit, a powerful display of solidarity, highlighted Inter’s commitment to supporting vital research.
A Meeting of minds and Mission
Marotta, welcomed by NeMO Chairman Marco Rasconi and a host of clinicians, researchers, and patients, including young Powerchair Football athletes, underscored the importance of collaborative efforts. the atmosphere was charged with emotion, a testament to the shared dedication to finding cures.
A Christmas Gift for Research
Inter’s initiative to fundraise for NeMO at Christmas 2024 is a shining example of corporate social obligation. This generous donation will enable the clinic to acquire cutting-edge equipment, crucial for advancing research into diseases like ALS, SMA, and muscular dystrophy.
NeMO’s Groundbreaking Research
Dr. Valeria Sansone, Clinical Director at NeMO, emphasized the critical role of this equipment in collecting biological samples. These samples are essential for understanding the biochemical and metabolic aspects of these complex diseases. The clinic’s relentless pursuit of a cure is driven by the meticulous collection and analysis of data.
2024 Research Highlights
In 2024 alone, the Clinical Research Center “Nanni Anselmi” at NeMO Milano conducted 55 clinical studies:
29 interventional trials testing new drug treatments
23 observational studies
* 3 expanded access programs (EAP) for compassionate use of drugs for rare diseases
This impressive volume of research underscores NeMO’s commitment to pushing the boundaries of medical knowledge.
A Message of Hope
marco Rasconi, President of the NeMO centers, expressed profound gratitude to Inter and Chairman Marotta. He highlighted the invaluable support as a beacon of hope for the community. The collaboration symbolizes a shared belief in the power of research to overcome seemingly insurmountable challenges.
